|
1
|
Miller RW: Contrasting epidemiology of
childhood osteosarcoma, Ewing's tumor, and rhabdomyosarcoma. Natl
Cancer Inst Monogr. 56:9–15. 1981.PubMed/NCBI
|
|
2
|
Ottaviani G and Jaffe N: The Epidemiology
of Osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Provisor AJ, Ettinger LJ, Nachman JB,
Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES,
Kisker CT and Miser JS: Treatment of nonmetastatic osteosarcoma of
the extremity with preoperative and postoperative chemotherapy: A
report from the Children's Cancer Group. J Clin Oncol. 15:76–84.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gianferante DM, Mirabello L and Savage SA:
Germline and somatic genetics of osteosarcoma-connecting aetiology,
biology and therapy. Nat Rev Endocrinol. 13:480–491. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Milane L, Singh A, Mattheolabakis G,
Suresh M and Amiji MM: Exosome mediated communication within the
tumor microenvironment. J Control Release. 219:278–294. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Teng X, Chen L, Chen W, Yang J, Yang Z and
Shen Z: Mesenchymal stem cell-derived exosomes improve the
microenvironment of infarcted myocardium contributing to
angiogenesis and anti-inflammation. Cell Physiol Biochem.
37:2415–2424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baixauli F, López-Otín C and Mittelbrunn
M: Exosomes and autophagy: Coordinated mechanisms for the
maintenance of cellular fitness. Front Immunol. 5:4032014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nair R, Santos L, Awasthi S, von Erlach T,
Chow LW, Bertazzo S and Stevens MM: Extracellular vesicles derived
from preosteoblasts influence embryonic stem cell differentiation.
Stem Cells Dev. 23:1625–1635. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tkach M and Théry C: Communication by
extracellular vesicles: Where we are and where we need to go. Cell.
164:1226–1232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao L, Liu W, Xiao J and Cao B: The role
of exosomes and ‘exosomal shuttle microRNA’ in tumorigenesis and
drug resistance. Cancer Lett. 356((2 Pt B)): 339–346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen WX, Liu XM, Lv MM, Chen L, Zhao JH,
Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ and Tang JH: Exosomes from
drug-resistant breast cancer cells transmit chemoresistance by a
horizontal transfer of microRNAs. PLoS One. 9:e952402014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Robbins PD and Morelli AE: Regulation of
immune responses by extracellular vesicles. Nat Rev Immunol.
14:195–208. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santos JC, Lima NDS, Sarian LO, Matheu A,
Ribeiro ML and Derchain SFM: Exosome-mediated breast cancer
chemoresistance via miR-155 transfer. Sci Rep. 8:8292018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang T, Lv H, Lv G, Li T, Wang C, Han Q,
Yu L, Su B, Guo L, Huang S, et al: Tumor-derived exosomal
miR-1247-3p induces cancer-associated fibroblast activation to
foster lung metastasis of liver cancer. Nat Commun. 9:1912018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Safaei R, Larson BJ, Cheng TC, Gibson MA,
Otani S, Naerdemann W and Howell SB: Abnormal lysosomal trafficking
and enhanced exosomal export of cisplatin in drug-resistant human
ovarian carcinoma cells. Mol Cancer Ther. 4:1595–1604. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Corcoran C, Rani S and O'Driscoll L:
miR-34a is an intracellular and exosomal predictive biomarker for
response to docetaxel with clinical relevance to prostate cancer
progression. Prostate. 74:1320–1334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lv MM, Zhu XY, Chen WX, Zhong SL, Hu Q, Ma
TF, Zhang J, Chen L, Tang JH and Zhao JH: Exosomes mediate drug
resistance transfer in MCF-7 breast cancer cells and a probable
mechanism is delivery of P-glycoprotein. Tumour Biol.
35:10773–10779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Federici C, Petrucci F, Caimi S, Cesolini
A, Logozzi M, Borghi M, D'Ilio S, Lugini L, Violante N, Azzarito T,
et al: Exosome release and low pH belong to a framework of
resistance of human melanoma cells to cisplatin. PLoS One.
9:e881932014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu D, Wu Y, Zhang X, Lv MM, Chen WX, Chen
X, Yang SJ, Shen H, Zhong SL, Tang JH and Zhao JH: Exosomes from
adriamycin-resistant breast cancer cells transmit drug resistance
partly by delivering miR-222. Tumour Biol. 37:3227–3235. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng Z, Rong Y, Teng Y, Zhuang X,
Samykutty A, Mu J, Zhang L, Cao P, Yan J, Miller D and Zhang HG:
Exosomes miR-126a released from MDSC induced by DOX treatment
promotes lung metastasis. Oncogene. 36:639–651. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei F, Ma C, Zhou T, Dong X, Luo Q, Geng
L, Ding L, Zhang Y, Zhang L, Li N, et al: Exosomes derived from
gemcitabine-resistant cells transfer malignant phenotypic traits
via delivery of miRNA-222-3p. Mol Cancer. 16:1322017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T,
Wen H, Yang Y, Wang S, Wang J, et al: Exosomal microRNA-32-5p
induces multidrug resistance in hepatocellular carcinoma via the
PI3K/Akt pathway. J Exp Clin Cancer Res. 37:522018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun X, Dai G, Yu L, Hu Q, Chen J and Guo
W: miR-143-3p inhibits the proliferation, migration and invasion in
osteosarcoma by targeting FOSL2. Sci Rep. 8:6062018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Li Q, Niu X, Wang G, Zheng S, Fu G
and Wang Z: miR-143 inhibits bladder cancer cell proliferation and
enhances their sensitivity to gemcitabine by repressing IGF-1R
signaling. Oncol Lett. 13:435–440. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, He J, Xu H, Xu L and Li N: MiR-143
targets CTGF and exerts tumour-suppressing functions in epithelial
ovarian cancer. Am J Transl Res. 8:2716–2726. 2016.PubMed/NCBI
|
|
27
|
Chen L, Yao H, Wang K and Liu X: Long
non-coding RNA MALAT1 regulates ZEB1 expression by sponging
miR-143-3p and promotes hepatocellular carcinoma progression. J
Cell Biochem. 118:4836–4843. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li D, Hu J, Song H, Xu H, Wu C, Zhao B,
Xie D, Wu T, Zhao J and Fang L: miR-143-3p targeting LIM domain
kinase 1 suppresses the progression of triple-negative breast
cancer cells. Am J Transl Res. 9:2276–2285. 2017.PubMed/NCBI
|
|
29
|
Yang L, Li H and Huang A: MiR-429 and
MiR-143-3p function as diagnostic and prognostic markers for
osteosarcoma. Clin Lab. 66:2020. View Article : Google Scholar
|
|
30
|
Zhou J, Wu S, Chen Y, Zhao J, Zhang K,
Wang J and Chen S: microRNA-143 is associated with the survival of
ALDH1+CD133+ osteosarcoma cells and the chemoresistance of
osteosarcoma. Exp Biol Med (Maywood). 240:867–875. 2015. View Article : Google Scholar : PubMed/NCBI
|
